Aprea Therapeutics
Precision oncology for cancers with specific genetic alterations to potentially minimize damage to healthy cells
United States
17 employees
Post-IPO Equity
Total: $124.50M
Biotechnology, Health Care +2
General Information
United States
BounceWatch is an independent company data service, not affiliated with Aprea Therapeutics. To contact Aprea Therapeutics, visit aprea.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Aprea Therapeutics compare?
A PDF of Aprea Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Aprea Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About Aprea Therapeutics
Business keywords: biotech, anticancer compounds, p53 reactivation therapy, APR-246, small molecule drug candidate, clinical trials, Stockholm, Sweden, Klas Wiman, Galina Selivanova
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | $16.00M | 5 |
|
11 Mar 2024 |
| Post IPO Equity | $5.50M | - |
|
22 Feb 2023 |
| Grant | $2.00M | 1 |
National Cancer Institute
|
15 Feb 2023 |
| Post IPO Equity | Undisclosed | 1 |
|
25 Aug 2022 |
| Series C | €5.00M | 1 |
|
28 Feb 2019 |
| Series C | €50.00M | 7 |
|
30 Nov 2018 |
| Series B | €46.00M | 4 |
|
09 Mar 2016 |
| Series A | Undisclosed | 2 |
|
01 Jan 2013 |
Aprea Therapeutics Alternatives & Competitors
View All Alternatives
Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiat...
A precision oncology company focused on small molecule therapies optimized to target key driver mech...
A leading precision oncology company focused on synthetic lethality
FAQ About Aprea Therapeutics
Source: BounceWatch company record for Aprea Therapeutics, https://bouncewatch.com/company/aprea, updated 30 December 2024. When citing, please name BounceWatch and link this page.
